Overview

Efficacy Study of Escitalopram for Depression in Patients With Diabetes

Status:
Unknown status
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Patients with diabetes and major depression treated with Escitalopram might experience significant improvement in depression and anxiety scores; functional ability; diabetes-related self-care; and pain symptoms
Phase:
Phase 4
Details
Lead Sponsor:
Sheba Medical Center
Treatments:
Citalopram
Dexetimide